Helping People Survive with Bladder Urothelial Carcinoma
“A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival”
The investigators would like to compare the progression free survival, overall survival, quality of life, and safety outcomes of patients receiving versus not receiving a 2nd transurethral resection of bladder tumor.
Procedure - re-TURBT
2nd bladder biopsy within 4-6 weeks of initial biopsy
Drug - 6 weeks BCG instillation
standard 6 weeks of BCG induction
A Pilot, Single-centre, Randomized, 5-year, Parallel-group, Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival